Telemetric home monitoring of intracranial pressure—where are we now

Intracranial Atherosclerosis: Where Are We Now?

Intracranial atherosclerosis (ICAS) is an important cause of stroke in Asians, Africans, and Hispanics. Because these ethnic groups account for more than 70% of the world’s population, ICAS can be considered a major cause of ischemic stroke worldwide. Nevertheless, as compared to extracranial atherosclerosis, ICAS has been largely neglected in the literature. Now, partly due to the development ...

Reflection for the undergraduate on writing in the portfolio: where are we now and where are we going?

Introduction: The portfolio can be seen as a tool for assessmentof a variety of learning activities that differ in content, usage, andassessment. The portfolio not only meets the learner’s educationalneeds but also the political and public reassurance demand thatthe health professional has achieved the required competency ofthe curriculum that allows him or her to practice safely with orwithout...

Monitoring patients on antimalarials: where are we now?

Now We Are Six

1 Sabin Vaccine Institute and Texas Children’s Hospital Center for Vaccine Development, Departments of Pediatrics and Molecular Virology & Microbiology, Baylor College of Medicine, Houston, Texas, United States of America, 2 National School of Tropical Medicine, Baylor College of Medicine, Houston, Texas, United States of America, 3 James A. Baker III Institute for Public Policy, Rice Universit...

MMR: where are we now?

T he combined measles, mumps and rubella (MMR) vaccine was introduced to the UK in 1988 and uptake of the vaccine rose rapidly to a high of 92%. In 1992, brands containing the Urabe strain of the mumps vaccine virus were withdrawn after it was noted to be associated with an increased risk of aseptic meningitis. This did not appear to have a deleterious effect on uptake. In 1995, a paper was pub...